SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-091094
Filing Date
2023-11-29
Accepted
2023-11-29 16:47:52
Documents
14
Period of Report
2023-11-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea189246-8k_adialpharma.htm   iXBRL 8-K 26919
2 ADIAL PHARMACEUTICALS, INC. PRESS RELEASE DATED NOVEMBER 29, 2023 ea189246ex99-1_adialpharma.htm EX-99.1 8249
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3998
  Complete submission text file 0001213900-23-091094.txt   219371

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE adil-20231129.xsd EX-101.SCH 3024
5 XBRL LABEL FILE adil-20231129_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE adil-20231129_pre.xml EX-101.PRE 22365
8 EXTRACTED XBRL INSTANCE DOCUMENT ea189246-8k_adialpharma_htm.xml XML 3395
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 231452984
SIC: 2834 Pharmaceutical Preparations